ACELRX PHARMACEUTICALS INC (ACRX) Forecast, Price Target & Analyst Ratings

NASDAQ:ACRX • US00444T2096

Current stock price

0.86 USD
+0.06 (+7.5%)
At close:
0.8719 USD
+0.01 (+1.38%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ACELRX PHARMACEUTICALS INC (ACRX).

Forecast Snapshot

Consensus Price Target

Price Target
$4.72
+ 448.55% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 28, 2024
Period
Q4 / 2023
EPS Estimate
-$0.19
Revenue Estimate
286.62K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$4.72
Upside
+ 448.55%
From current price of $0.86 to mean target of $4.72, Based on 8 analyst forecasts
Low
$4.29
Median
$4.72
High
$5.25

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for ACRX. The average price target is 4.72 USD. This implies a price increase of 448.55% is expected in the next year compared to the current price of 0.86.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ACRX Current Analyst RatingACRX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

ACRX Historical Analyst RatingsACRX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
ACRX was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ACRX.
In the previous month the buy percentage consensus was at a similar level.
ACRX was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-12-07HC Wainwright & Co.Reiterate Buy -> Buy
2023-10-02Alliance Global PartnersInitiate Buy
2023-09-25HC Wainwright & Co.Maintains Buy -> Buy
2023-08-18HC Wainwright & Co.Upgrade Neutral -> Buy
2021-08-17HC Wainwright & Co.Maintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 28, 2024
Period
Q4 / 2023
EPS Estimate
-$0.19
Revenue Estimate
286.62K
Revenue Q2Q
14.65%
EPS Q2Q
81.13%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
100.00%
EPS (1 Month)
0.00%
EPS (3 Months)
26.00%

Next Earnings Summary

ACRX is expected to report earnings on 3/28/2024. The consensus EPS estimate for the next earnings is -0.19 USD and the consensus revenue estimate is 286.62K USD.
The next earnings revenue estimate has been revised upward by 100% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
ACRX revenue by date.ACRX revenue by date.
5.42M
136.68%		2.82M
-47.97%		1.77M
-37.23%		520.71K
-70.58%		1.392M
167.33%		2.554M
83.48%		12.579M
392.52%		28.989M
130.46%		60.886M
110.03%
EBITDA
YoY % growth
ACRX ebitda by date.ACRX ebitda by date.
-39.11M
25.56%		-34M
13.07%		-30.03M
11.68%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ACRX ebit by date.ACRX ebit by date.
-40.96M
24.44%		-35.97M
12.18%		-31.68M
11.93%		-16.938M
46.53%		-17.817M
-5.19%		-19.016M
-6.73%		-15.343M
19.32%		2.523M
116.44%		30.759M
1,119.14%
Operating Margin
ACRX operating margin by date.ACRX operating margin by date.
-755.72%-1,275.53%-1,789.83%-3,252.89%-1,279.95%-744.55%-121.97%8.70%50.52%
EPS
YoY % growth
ACRX eps by date.ACRX eps by date.
-9.60
28.36%		-5.80
39.58%		-4.34
25.17%		-1.20
72.27%		-0.80
33.90%		-0.78
2.56%		-0.58
25.66%		0.08
114.16%		0.93
1,037.50%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.19
81.13%		-0.24
67.36%		-0.27
33.70%		-0.29
-257.00%		-0.29
-51.35%
Revenue
Q2Q % growth		286.62K
14.65%
-100.00%
-100.00%
-100.00%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-3.86M
47.69%		-4.59M
13.88%		-4.794M
-20.76%		-4.896M
-47.92%		-4.59M
-18.91%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ACRX Yearly Revenue VS EstimatesACRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M
ACRX Yearly EPS VS EstimatesACRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 -5 -10 -15 -20

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
22.12%
EPS Next 5 Year
15.09%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-25.27%
Revenue Next 5 Year
36.49%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ACELRX PHARMACEUTICALS INC / ACRX Forecast FAQ

Can you provide the average price target for ACELRX PHARMACEUTICALS INC stock?

8 analysts have analysed ACRX and the average price target is 4.72 USD. This implies a price increase of 448.55% is expected in the next year compared to the current price of 0.86.

Can you provide the upcoming earnings date for ACELRX PHARMACEUTICALS INC?

ACELRX PHARMACEUTICALS INC (ACRX) will report earnings on 2024-03-28, after the market close.

What are the consensus estimates for ACRX stock next earnings?

The consensus EPS estimate for the next earnings of ACELRX PHARMACEUTICALS INC (ACRX) is -0.19 USD and the consensus revenue estimate is 286.62K USD.

What is the expected long term growth rate for ACELRX PHARMACEUTICALS INC (ACRX)?

The expected long term growth rate for ACELRX PHARMACEUTICALS INC (ACRX) is -25.27%.